azathioprine has been researched along with Dermatitis, Atopic in 77 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Azathioprine is frequently used in severe eczema." | 7.88 | Thiopurine metabolite levels in patients with atopic dermatitis and/or chronic hand/foot eczema treated with azathioprine. ( Bruijnzeel-Koomen, CAF; de Bruin-Weller, MS; de Graaf, M; Garritsen, FM; van den Broek, MPH; van der Schaft, J; van Schaik, RH, 2018) |
| "Azathioprine is frequently used in severe eczema." | 3.88 | Thiopurine metabolite levels in patients with atopic dermatitis and/or chronic hand/foot eczema treated with azathioprine. ( Bruijnzeel-Koomen, CAF; de Bruin-Weller, MS; de Graaf, M; Garritsen, FM; van den Broek, MPH; van der Schaft, J; van Schaik, RH, 2018) |
| "We present a case of drug-induced alveolitis following infliximab and azathioprine for the treatment of severe, generalised psoriasis and atopic eczema without pre-existing lung disease." | 3.74 | [Drug-induced alveolitis associated with infliximab/azathioprine therapy]. ( Dercken, HG; El-Hag, K; Hölzle, E; Prenzel, R, 2008) |
| " He had CD4 lymphocytopenia during azathioprine and topical corticosteroid therapy for atopic dermatitits (AD)." | 3.69 | Kaposi's sarcoma during immunosuppressive therapy for atopic dermatitis. ( Janssens, P; Lachapelle, JM; Lambert, M; Tennstedt, D; Vandercam, B, 1997) |
| "Azathioprine has an important role in treatment of many inflammatory dermatoses." | 3.69 | Azathioprine in dermatology: a survey of current practice in the U.K. ( English, JS; Gawkrodger, DJ; Lear, JT; Tan, BB, 1997) |
| "Azathioprine is an accessible drug for patients in many countries, including underdeveloped countries, and therefore it is used by many dermatologists in moderate and severe AD." | 2.82 | The use of azathioprine in atopic dermatitis: A review. ( Bracho-Borro, M; Franco-Ruiz, PA; Magaña, M, 2022) |
| "Patients with severe atopic eczema frequently require systemic treatment to control their disease." | 2.76 | A randomized trial of methotrexate versus azathioprine for severe atopic eczema. ( Bos, JD; Leeflang, MM; Roekevisch, E; Schmitt, J; Schram, ME; Spuls, PI, 2011) |
| " TPMT-based dosing seemed to reduce predicted toxicity, and drug efficacy was maintained." | 2.72 | Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. ( Gray, JC; Meggitt, SJ; Reynolds, NJ, 2006) |
| "Leukopenia was observed in two patients and deranged liver enzymes in eight during treatment with azathioprine." | 2.70 | Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. ( Agarwal, S; Ahmed, I; Barclay, G; Berth-Jones, J; Graham-Brown, RA; Hotchkiss, K; Takwale, A; Tan, E, 2002) |
| "Atopic dermatitis is a common, chronic pruritic condition affecting both children and adults, which has a negative impact on the quality of life." | 2.53 | Guidelines for the Management of Atopic Dermatitis in Singapore. ( Chan, YC; Chandran, NS; Ho, MS; Koh, MJ; Lim, YL; Tang, MB; Tay, YK; Thirumoorthy, T, 2016) |
| " Safety data were compared by calculating the weekly incidence rates (as percentages) for adverse events." | 2.50 | Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. ( Kuester, D; Limpens, J; Roekevisch, E; Schmitt, J; Spuls, PI, 2014) |
| "The optimal treatment of atopic dermatitis requires regular medical supervision." | 2.42 | [Systemic therapy of atopic dermatitis]. ( Breuer, K; Heratizadeh, A; Kapp, A; Werfel, T, 2003) |
| " The mean initial dosage of AZA was 1." | 1.51 | A Retrospective Study of Systemic Treatment of Severe Atopic Dermatitis With Azathioprine: Effectiveness and Tolerance in 11 Pediatric Patients. ( Hernández-Martín, A; Knöpfel, N; Noguera-Morel, L; Torrelo, A, 2019) |
| "Oral azathioprine was associated with few pronounced adverse effects for the duration of use and dosage in this cohort." | 1.42 | The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring. ( Bragoli, W; Fuggle, NR; Glover, M; Kinsler, VA; Mahto, A; Martinez, AE, 2015) |
| "Atopic dermatitis is the most common chronic inflammatory skin disease with high prevalence rates in adults and even higher among children." | 1.42 | The anti-IL-4 receptor alpha antibody dupilumab: facing a new era in treating atopic dermatitis. ( Luger, TA; Tsianakas, A, 2015) |
| "In this third of 4 sections, treatment of atopic dermatitis with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option." | 1.40 | Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. ( Begolka, WS; Berger, TG; Bergman, JN; Block, J; Chamlin, SL; Cohen, DE; Cooper, KD; Cordoro, KM; Davis, DM; Eichenfield, LF; Elmets, CA; Feldman, SR; Hanifin, JM; Harrod, CG; Krol, A; Margolis, DJ; Paller, AS; Schwarzenberger, K; Sidbury, R; Silverman, RA; Simpson, EL; Tom, WL; Williams, HC, 2014) |
| "Azathioprine therapy was associated with clinical improvement in all but 1 patient." | 1.39 | Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring. ( Caufield, M; Tom, WL, 2013) |
| "Our experience shows that, when adjusted to thiopurine methyltransferase activity, azathioprine is a safe drug for the treatment of children with severe atopic dermatitis." | 1.36 | [Safety of azathioprine therapy adjusted to thiopurine methyltransferase activity in the treatment of infantile atopic dermatitis. Report on 7 cases]. ( Borrego, L; Islas, D; Martel, RM; Melwani, P; Peñate, Y, 2010) |
| "Azathioprine was stopped in one female after 4 months due to lack of efficacy." | 1.35 | Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults. ( Ching, GK; Chow, CM; Hon, KL; Lee, KK; Leung, TF; Ng, PC, 2009) |
| "A 61-year-old Chinese man with severe atopic eczema developed moderate myelosuppression with standard doses of azathioprine." | 1.35 | TPMT*26 (208F-->L), a novel mutation detected in a Chinese. ( Aw, DC; Kham, SK; Soh, CK; Yeoh, AE, 2009) |
| "We suggest that food hypersensitivity should be ruled out in patients with hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis." | 1.35 | Hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis in a toddler with food hypersensitivity. ( Estrada-Reyes, E; Gamboa-Marrufo, JD; Hernnández-Román, MP; Nava-Ocampo, AA; Valencia-Herrera, A, 2008) |
| "Effective treatment of severe adult atopic eczema may necessitate the use of agents such as systemic steroids, PUVA or cyclosporin, which are associated with significant morbidity." | 1.30 | The use of azathioprine in severe adult atopic eczema. ( Baldwin, P; Buckley, DA; Rogers, S, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (5.19) | 18.7374 |
| 1990's | 6 (7.79) | 18.2507 |
| 2000's | 17 (22.08) | 29.6817 |
| 2010's | 43 (55.84) | 24.3611 |
| 2020's | 7 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bracho-Borro, M | 1 |
| Franco-Ruiz, PA | 1 |
| Magaña, M | 1 |
| de Graaf, M | 3 |
| Janmohamed, SR | 1 |
| Schuttelaar, MLA | 1 |
| Agner, T | 2 |
| Alfonso, JH | 1 |
| De Schepper, S | 1 |
| Deleuran, M | 2 |
| Despontin, K | 1 |
| Elenius, V | 1 |
| Ghislain, PD | 1 |
| Huilaja, L | 1 |
| Johansson, EK | 1 |
| Kvenshagen, BK | 1 |
| Mandelin, JM | 1 |
| Olset, H | 1 |
| Svensson, A | 2 |
| van Tuyll van Serooskerken, AM | 1 |
| Thyssen, JP | 1 |
| Vestergaard, C | 2 |
| Wollenberg, A | 1 |
| Kinberger, M | 1 |
| Arents, B | 1 |
| Aszodi, N | 1 |
| Avila Valle, G | 1 |
| Barbarot, S | 1 |
| Bieber, T | 3 |
| Brough, HA | 1 |
| Calzavara Pinton, P | 1 |
| Christen-Zäch, S | 1 |
| Dittmann, M | 1 |
| Dressler, C | 1 |
| Fink-Wagner, AH | 1 |
| Fosse, N | 1 |
| Gáspár, K | 1 |
| Gerbens, L | 1 |
| Gieler, U | 1 |
| Girolomoni, G | 1 |
| Gregoriou, S | 1 |
| Mortz, CG | 1 |
| Nast, A | 1 |
| Nygaard, U | 1 |
| Redding, M | 1 |
| Rehbinder, EM | 1 |
| Ring, J | 1 |
| Rossi, M | 1 |
| Serra-Baldrich, E | 1 |
| Simon, D | 2 |
| Szalai, ZZ | 1 |
| Szepietowski, JC | 1 |
| Torrelo, A | 2 |
| Werfel, T | 3 |
| Flohr, C | 5 |
| Cheirif-Wolosky, O | 1 |
| Elizalde-Jiménez, IG | 1 |
| Romero, MTG | 1 |
| Singh, P | 1 |
| Silverberg, JI | 1 |
| Drucker, AM | 1 |
| Ellis, AG | 1 |
| Bohdanowicz, M | 1 |
| Mashayekhi, S | 1 |
| Yiu, ZZN | 1 |
| Rochwerg, B | 1 |
| Di Giorgio, S | 1 |
| Arents, BWM | 1 |
| Burton, T | 1 |
| Spuls, PI | 7 |
| Küster, D | 1 |
| Siegels, D | 1 |
| Schmitt, J | 5 |
| Pino Lopez, J | 1 |
| Kromer, C | 1 |
| Herr, R | 1 |
| Schmieder, A | 1 |
| Bayerl, C | 1 |
| Schaarschmidt, ML | 1 |
| Prezzano, JC | 1 |
| Beck, LA | 3 |
| Davis, DM | 2 |
| Borok, J | 1 |
| Udkoff, J | 1 |
| Lio, P | 1 |
| Spergel, J | 1 |
| Garritsen, FM | 4 |
| van der Schaft, J | 5 |
| Bruijnzeel-Koomen, CAF | 2 |
| van Schaik, RH | 2 |
| van den Broek, MPH | 3 |
| de Bruin-Weller, MS | 6 |
| Roekevisch, E | 6 |
| Schram, ME | 3 |
| Leeflang, MMG | 3 |
| Brouwer, MWD | 2 |
| Gerbens, LAA | 2 |
| Bos, JD | 3 |
| Hijnen, DJ | 1 |
| Hamann, SAS | 1 |
| Lacour, JP | 1 |
| van den Heuvel, JM | 1 |
| Bruijnzeel-Koomen, CAFM | 1 |
| Maitland-van der Zee, AH | 1 |
| Ordóñez Rubiano, MF | 1 |
| Arenas, CM | 1 |
| Chalela, JG | 1 |
| von Kobyletzki, LB | 1 |
| Weidinger, S | 2 |
| Kabashima, K | 1 |
| Irvine, AD | 2 |
| Noguera-Morel, L | 1 |
| Knöpfel, N | 1 |
| Hernández-Martín, A | 1 |
| Vicente Villa, A | 1 |
| Solman, L | 1 |
| Lloyd-Lavery, A | 1 |
| Grindlay, DJC | 1 |
| Rogers, NK | 1 |
| Thomas, KS | 1 |
| Harman, KE | 1 |
| Alexander, H | 1 |
| Patton, T | 1 |
| Jabbar-Lopez, ZK | 1 |
| Manca, A | 1 |
| Kuester, D | 1 |
| Limpens, J | 1 |
| Sidbury, R | 2 |
| Cohen, DE | 1 |
| Cordoro, KM | 1 |
| Berger, TG | 1 |
| Bergman, JN | 1 |
| Chamlin, SL | 1 |
| Cooper, KD | 1 |
| Feldman, SR | 1 |
| Hanifin, JM | 1 |
| Krol, A | 1 |
| Margolis, DJ | 1 |
| Paller, AS | 2 |
| Schwarzenberger, K | 1 |
| Silverman, RA | 1 |
| Simpson, EL | 1 |
| Tom, WL | 2 |
| Williams, HC | 1 |
| Elmets, CA | 1 |
| Block, J | 1 |
| Harrod, CG | 1 |
| Begolka, WS | 1 |
| Eichenfield, LF | 2 |
| Thomsen, SF | 1 |
| Karlsmark, T | 1 |
| Clemmensen, KK | 1 |
| Graversgaard, C | 1 |
| Ibler, KS | 1 |
| Jemec, GB | 1 |
| Fuggle, NR | 1 |
| Bragoli, W | 1 |
| Mahto, A | 1 |
| Glover, M | 1 |
| Martinez, AE | 1 |
| Kinsler, VA | 1 |
| Deinum, J | 1 |
| van den Broek, MP | 1 |
| Bruijnzeel-Koomen, CA | 2 |
| Tsianakas, A | 1 |
| Luger, TA | 1 |
| Notaro, ER | 1 |
| Politiek, K | 1 |
| van den Reek, JM | 1 |
| Kievit, W | 1 |
| de Jong, EM | 1 |
| Schuttelaar, ML | 1 |
| Védie, AL | 1 |
| Ezzedine, K | 1 |
| Amazan, E | 1 |
| Boralevi, F | 1 |
| Milpied, B | 1 |
| Taïeb, A | 1 |
| Seneschal, J | 1 |
| Bagherani, N | 1 |
| Smoller, BR | 1 |
| Tan, SH | 1 |
| Yew, YW | 1 |
| Tay, YK | 1 |
| Chan, YC | 1 |
| Chandran, NS | 1 |
| Ho, MS | 1 |
| Koh, MJ | 1 |
| Lim, YL | 1 |
| Tang, MB | 1 |
| Thirumoorthy, T | 1 |
| Riis, JL | 1 |
| Hjuler, KF | 1 |
| Iversen, L | 1 |
| Jakobsen, L | 1 |
| Deleuran, MS | 1 |
| Olsen, M | 1 |
| Totri, CR | 1 |
| Logan, K | 1 |
| Proudfoot, L | 1 |
| Lara-Corrales, I | 1 |
| Sugarman, J | 1 |
| Tom, W | 1 |
| Siegfried, E | 1 |
| Cordoro, K | 1 |
| Abraham, S | 1 |
| Trautmann, F | 1 |
| Stephan, V | 1 |
| Fölster-Holst, R | 1 |
| Homey, B | 1 |
| Novak, N | 1 |
| Sticherling, M | 1 |
| Augustin, M | 1 |
| Kleinheinz, A | 1 |
| Elsner, P | 1 |
| Campbell, LE | 1 |
| Irwin McLean, WH | 1 |
| Kezic, S | 1 |
| Middelkamp-Hup, MA | 1 |
| Chong, JH | 1 |
| Koh, MJA | 1 |
| Hughes, R | 1 |
| Collins, P | 1 |
| Rogers, S | 2 |
| Hon, KL | 1 |
| Ching, GK | 1 |
| Leung, TF | 1 |
| Chow, CM | 1 |
| Lee, KK | 1 |
| Ng, PC | 1 |
| Wolverton, SE | 1 |
| Kham, SK | 1 |
| Soh, CK | 1 |
| Aw, DC | 1 |
| Yeoh, AE | 1 |
| Shaw, MG | 1 |
| Burkhart, CN | 1 |
| Morrell, DS | 1 |
| Martel, RM | 1 |
| Melwani, P | 1 |
| Islas, D | 1 |
| Peñate, Y | 1 |
| Borrego, L | 1 |
| Lai, SW | 1 |
| Wang, YC | 1 |
| Wang, CH | 1 |
| Huang, TY | 1 |
| Wee, JS | 1 |
| Marinaki, A | 1 |
| Smith, CH | 1 |
| Thiryayi, WA | 1 |
| Leeflang, MM | 1 |
| Denby, KS | 1 |
| Caufield, M | 1 |
| Tan, AU | 1 |
| Gonzalez, ME | 1 |
| Murphy, LA | 1 |
| Atherton, D | 1 |
| Berth-Jones, J | 1 |
| Takwale, A | 1 |
| Tan, E | 1 |
| Barclay, G | 1 |
| Agarwal, S | 1 |
| Ahmed, I | 1 |
| Hotchkiss, K | 1 |
| Graham-Brown, RA | 1 |
| Heratizadeh, A | 1 |
| Breuer, K | 1 |
| Kapp, A | 1 |
| Malthieu, F | 1 |
| Guillet, G | 1 |
| Larregue, M | 1 |
| Bodemer, C | 1 |
| Bernier, C | 1 |
| Meggitt, SJ | 2 |
| Gray, JC | 1 |
| Reynolds, NJ | 2 |
| Favrot, C | 1 |
| Reichmuth, P | 1 |
| Olivry, T | 1 |
| El-Hag, K | 1 |
| Dercken, HG | 1 |
| Prenzel, R | 1 |
| Hölzle, E | 1 |
| Estrada-Reyes, E | 1 |
| Hernnández-Román, MP | 1 |
| Gamboa-Marrufo, JD | 1 |
| Valencia-Herrera, A | 1 |
| Nava-Ocampo, AA | 1 |
| Lear, JT | 2 |
| English, JS | 2 |
| Jones, P | 1 |
| Smith, AG | 1 |
| Vandercam, B | 1 |
| Lachapelle, JM | 1 |
| Janssens, P | 1 |
| Tennstedt, D | 1 |
| Lambert, M | 1 |
| Tan, BB | 1 |
| Gawkrodger, DJ | 1 |
| Buckley, DA | 1 |
| Baldwin, P | 1 |
| Lyons, F | 1 |
| Kuanprasert, N | 1 |
| Herbert, O | 1 |
| Barnetson, RS | 1 |
| Numata, T | 1 |
| Mizuno, N | 1 |
| Russell Jones, R | 1 |
| Anderson, C | 1 |
| Gunnar, S | 1 |
| Johansson, O | 1 |
| Juhlin, L | 1 |
| Thomas, F | 1 |
| Owens, L | 1 |
| Thomas, J | 1 |
| Wolf, JS | 1 |
| Volk, M | 1 |
| Mendez, G | 1 |
| Lee, HM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Baricitinib Versus Azathioprine in Combination With Topical Corticosteroids For Patients With Moderate-to-Severe Atopic Dermatitis[NCT05969730] | 40 participants (Anticipated) | Interventional | 2023-08-15 | Recruiting | |||
| Effects of Abrocitinib Treatment of Moderate to Severe Atopic Dermatitis on Skin Barrier Function[NCT05140239] | 20 participants (Anticipated) | Observational | 2022-09-01 | Recruiting | |||
| A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Nutritional Intervention Study to Examine the Clinical and Immunological Effects of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed[NCT04662619] | 273 participants (Actual) | Interventional | 2020-12-18 | Active, not recruiting | |||
| Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis: A Randomized, Single-blinded, Prospective Crossover Controlled Trial[NCT03397979] | 63 participants (Actual) | Interventional | 2011-11-14 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
19 reviews available for azathioprine and Dermatitis, Atopic
| Article | Year |
|---|---|
The use of azathioprine in atopic dermatitis: A review.
Topics: Azathioprine; Dermatitis, Atopic; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosup | 2022 |
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Dermatitis, Atopic; Dermatolog | 2020 |
Long-Term Treatment of Atopic Dermatitis.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Azathioprine; Baths; Calcineurin Inhibitors; Cyc | 2017 |
Atopic dermatitis: phototherapy and systemic therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Dermatitis, A | 2017 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com | 2018 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com | 2018 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com | 2018 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Com | 2018 |
What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 1: treatment and prevention.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Anti-Allergic Agents; Azathi | 2019 |
Novel systemic therapies in atopic dermatitis: what do we need to fulfil the promise of a treatment revolution?
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Randomized Controlled Trials a | 2019 |
Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Glucocorticoids; Humans; Immunosuppressive Agents; I | 2014 |
Systemic Agents for Severe Atopic Dermatitis in Children.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2015 |
Guidelines for the Management of Atopic Dermatitis in Singapore.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Calcineurin | 2016 |
Non-topical management of recalcitrant paediatric atopic dermatitis.
Topics: Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressiv | 2017 |
Systemic therapies for pediatric atopic dermatitis: a review for the primary care physician.
Topics: Algorithms; Anti-Bacterial Agents; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclospo | 2009 |
Systemic therapy of atopic dermatitis in children and adults.
Topics: Adrenal Cortex Hormones; Adult; Alitretinoin; Antibodies, Monoclonal; Azathioprine; Child; Cyclospor | 2011 |
Update on systemic therapies for atopic dermatitis.
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Enzyme Inhibitors; Female; Humans; Immunosuppressive | 2012 |
Management of severe atopic dermatitis in children.
Topics: Administration, Cutaneous; Adolescent; Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine | 2012 |
[Systemic therapy of atopic dermatitis].
Topics: Adjuvants, Immunologic; Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Animals; Anti-Bacte | 2003 |
[How should severe and chronic atopic dermatitis in children be managed?].
Topics: Azathioprine; Child; Chronic Disease; Dermatitis, Atopic; Humans; Immunologic Factors; Immunosuppres | 2005 |
[How should severe and chronic atopic dermatitis be managed in children?].
Topics: Azathioprine; Child; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Humans; Immunologic Factors; | 2005 |
Azathioprine for atopic dermatitis.
Topics: Azathioprine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressive Agents; Mercaptopur | 2001 |
7 trials available for azathioprine and Dermatitis, Atopic
| Article | Year |
|---|---|
Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Dermatologic Agents; Drug Administration Schedule; Drug Sub | 2018 |
Patients with atopic dermatitis with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Female; Filaggrin Proteins; Humans; Immunosuppressive Agent | 2017 |
A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; Methotrexat | 2011 |
Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.
Topics: Adolescent; Adult; Aged; Azathioprine; Cross-Over Studies; Dermatitis, Atopic; Double-Blind Method; | 2002 |
[Azatropin in severe atopic dermatitis: 24 cases].
Topics: Adult; Azathioprine; Child; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; Retr | 2005 |
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Immu | 2006 |
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Immu | 2006 |
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Immu | 2006 |
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Immu | 2006 |
Treatment of canine atopic dermatitis with azathioprine: a pilot study.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Azathioprine; Dermatitis, Atopic; Dog Diseases; | 2007 |
51 other studies available for azathioprine and Dermatitis, Atopic
| Article | Year |
|---|---|
Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe.
Topics: Adolescent; Azathioprine; Biological Products; Child; Child, Preschool; Cyclosporine; Delphi Techniq | 2022 |
European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy.
Topics: Adolescent; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Immunosuppressive | 2022 |
Systemic treatment for severe atopic dermatitis in children: a case series.
Topics: Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Mycop | 2022 |
Adverse event monitoring in patients on oral systemic medications for inflammatory skin disease.
Topics: Azathioprine; Cross-Sectional Studies; Cyclosporine; Dermatitis, Atopic; Drug Eruptions; Drug Monito | 2020 |
Drug survival rates and reasons for drug discontinuation in patients with atopic dermatitis: a retrospective study of adult outpatients.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Child, Preschool; C | 2021 |
Thiopurine metabolite levels in patients with atopic dermatitis and/or chronic hand/foot eczema treated with azathioprine.
Topics: Adult; Azathioprine; Chromatography, High Pressure Liquid; Dermatitis, Atopic; Eczema; Female; Guani | 2018 |
Methotrexate versus azathioprine in patients with atopic dermatitis: 2-year follow-up data.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Female; Filaggrin Proteins; Follow-Up Studies; Humans; Inte | 2018 |
Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema.
Topics: Adult; Allopurinol; Azathioprine; Chronic Disease; Dermatitis, Atopic; Drug Therapy, Combination; Ec | 2018 |
[Current and upcoming treatments of adult atopic dermatitis].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Boron Compounds; Bri | 2017 |
Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands.
Topics: Administration, Oral; Azathioprine; Cyclosporine; Databases, Factual; Dermatitis, Atopic; Drug Presc | 2018 |
UVA-1 phototherapy for the management of atopic dermatitis: a large retrospective study conducted in a low-middle income country.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Colombia; Dermatitis, Atopic; Develo | 2018 |
Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine.
Topics: Azathioprine; Dermatitis, Atopic; Follow-Up Studies; Humans; Methotrexate; Mycophenolic Acid | 2018 |
A Retrospective Study of Systemic Treatment of Severe Atopic Dermatitis With Azathioprine: Effectiveness and Tolerance in 11 Pediatric Patients.
Topics: Adolescent; Azathioprine; Child; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; | 2019 |
Azathioprine in the Treatment of Severe Pediatric Atopic Dermatitis: Experience in a Referral Hospital in Spain.
Topics: Azathioprine; Dermatitis, Atopic; Humans; Referral and Consultation; Spain | 2019 |
Systemic therapies for severe atopic dermatitis in children and adults.
Topics: Adult; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Male | 2013 |
Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.
Topics: Anti-Infective Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Histamine Antagonists; Humans | 2014 |
Outcome of treatment with azathioprine in severe atopic dermatitis: a 5-year retrospective study of adult outpatients.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Dermatologic Agents; Drug Administration Schedule; Female; | 2015 |
The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring.
Topics: Administration, Oral; Azathioprine; Child; Dermatitis, Atopic; Drug Monitoring; Drug-Related Side Ef | 2015 |
Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
Topics: Academic Medical Centers; Administration, Oral; Adult; Azathioprine; Cyclosporine; Dermatitis, Atopi | 2015 |
Increased liver enzyme levels during azathioprine treatment: beware of concomitant use of proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alanine Transaminase; Azathioprine; Dermatitis, Atopi | 2015 |
The anti-IL-4 receptor alpha antibody dupilumab: facing a new era in treating atopic dermatitis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; C | 2015 |
Drug survival for azathioprine and enteric-coated mycophenolate sodium in a long-term daily practice cohort of adult patients with atopic dermatitis.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Drug Resistance; Drug Substitution; Female; Humans; Kaplan- | 2016 |
Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study.
Topics: Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Dermatitis, Atopic; Drug Therapy, Combination; | 2016 |
Effectiveness of azathioprine pulse therapy in prolonging remission of psoriasis.
Topics: Azathioprine; Dermatitis, Atopic; Eczema; Humans; Psoriasis | 2017 |
Editorial on Guidelines for the Management of Atopic Dermatitis in Singapore.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclospori | 2016 |
Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study.
Topics: Adult; Aged; Ambulatory Care; Azathioprine; Case-Control Studies; Cyclosporine; Denmark; Dermatitis, | 2016 |
Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
Topics: Adult; Azathioprine; Canada; Child; Cyclosporine; Dermatitis, Atopic; Dermatology; Drug Prescription | 2017 |
Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
Topics: Adult; Alitretinoin; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Femal | 2017 |
Further experience of using azathioprine in the treatment of severe atopic dermatitis.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Dermatitis, Atopic; Female; Follow-Up Studies; Humans; | 2008 |
Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
Topics: Adolescent; Age Factors; Azathioprine; Child; Dermatitis, Atopic; Dose-Response Relationship, Drug; | 2009 |
Optimizing clinical use of azathioprine with newer pharmacogenetic data.
Topics: Azathioprine; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Administration Schedule; Fe | 2009 |
TPMT*26 (208F-->L), a novel mutation detected in a Chinese.
Topics: Asian People; Azathioprine; Dermatitis, Atopic; Genotype; Humans; Immunosuppressive Agents; Male; Me | 2009 |
[Safety of azathioprine therapy adjusted to thiopurine methyltransferase activity in the treatment of infantile atopic dermatitis. Report on 7 cases].
Topics: Adolescent; Azathioprine; Child; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; | 2010 |
Acute pancreatitis and erythema nodosum associated with azathioprine.
Topics: Acute Disease; Azathioprine; Dermatitis, Atopic; Dermatologic Agents; Erythema Nodosum; Humans; Immu | 2012 |
Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity.
Topics: Adult; Azathioprine; Bone Marrow Diseases; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Mal | 2011 |
Clinically integrated care. Shared care/blame arrangements.
Topics: Azathioprine; Bone Marrow Diseases; Dermatitis, Atopic; Drug Monitoring; Humans; Immunosuppressive A | 2011 |
Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring.
Topics: Administration, Oral; Adolescent; Azathioprine; Child; Child, Preschool; Dermatitis, Atopic; Female; | 2013 |
A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression.
Topics: Azathioprine; Biomarkers; Child; Child, Preschool; Dermatitis, Atopic; Drug Therapy, Combination; Er | 2002 |
[Drug-induced alveolitis associated with infliximab/azathioprine therapy].
Topics: Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Derm | 2008 |
Hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis in a toddler with food hypersensitivity.
Topics: Azathioprine; Bone Marrow Examination; Cell Separation; Combined Modality Therapy; Dermatitis, Atopi | 2008 |
Retrospective review of the use of azathioprine in severe atopic dermatitis.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Dermatitis, Atopic; | 1996 |
Kaposi's sarcoma during immunosuppressive therapy for atopic dermatitis.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Azathioprine; Betamethasone Valerate; CD4-P | 1997 |
Azathioprine in dermatology: a survey of current practice in the U.K.
Topics: Azathioprine; Bone Marrow; Dermatitis, Atopic; Dermatology; Drug Administration Schedule; Health Car | 1997 |
The use of azathioprine in severe adult atopic eczema.
Topics: Adult; Antimetabolites; Azathioprine; Clinical Trials as Topic; Dermatitis, Atopic; Drug Evaluation; | 1998 |
Treatment of common skin complaints--changing referral patterns.
Topics: Acne Vulgaris; Anthralin; Azathioprine; Dermatitis, Atopic; Dermatology; Diagnosis, Differential; Ec | 1997 |
Clinical improvement and significant reduction of total serum IgE in patients suffering from severe atopic dermatitis treated with oral azathioprine.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Azathioprine; Dermatitis, Atopic; Female; Huma | 2002 |
[Azathiopurine in treatment of atopic dermatitis and its influence to IgE level and various kinds of immunological tests (author's transl)].
Topics: Adult; Azathioprine; Dermatitis, Atopic; Humans; Immunoglobulin E; Male | 1975 |
Recurrent facial herpes associated with Chinese herbal remedy.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Drugs, Chinese Herbal; Facial Dermatoses; Herpes Simplex; H | 1991 |
The effect of some immunomodulating agents on the sensitization phase of experimental contact allergic reactions.
Topics: Animals; Azathioprine; Cyclophosphamide; Dermatitis, Atopic; Dermatitis, Contact; Dose-Response Rela | 1986 |
Immunoglobulin E in "healed" atopic dermatitis and after treatment with corticosteroids and azathioprine.
Topics: Adolescent; Adult; Aged; Azathioprine; Dermatitis, Atopic; Eczema; Female; gamma-Globulins; Humans; | 1970 |
Differential effect of immunosuppressive agents on T and B lymphocytes.
Topics: Animals; Antilymphocyte Serum; Azathioprine; B-Lymphocytes; Bacterial Infections; Concanavalin A; De | 1974 |